After Hours Summary: BBT boosted by analyst upgrade, IQ / MYOK lower on offering newsAfter Hours Gainers:
Companies trading higher in after hours in reaction to news: INO +5% (initiated with Overweight at Cantor Fitzgerald), X +1.5% (following CNBC FastMoney mention), BBT +1.1% (light volume; upgraded to Buy from Hold at Deutsche Bank), CELG +0.6% (submitted a New Drug Application to the FDA for ozanimod for the treatment of adults with relapsing forms of multiple sclerosis)
After Hours Losers:
Companies trading lower in after hours in reaction to news: IQ -4.5% (proposes offering of $1.05 bln convertible senior notes due 2025), MYOK -3.6% (announces proposed public offering of $200.0 mln of shares of common stock), ALDX -3.4% (schedules call for Tuesday, March 26 at 8 a.m. EDT to provide top-line results from the Phase 3 ALLEVIATE trial of topical ocular reproxalap in patients with allergic conjunctivitis), UTHR -1.1% (light volume; Sandoz announced the US availability of Treprostinil Injection, the first fully substitutable AP rated generic version of Remodulin (treprostinil) Injection, sold by United Therapeutics Corporation)
![]()
Closing Stock Market SummaryThe S&P 500 decreased 0.1% on Monday in a session that showed little conviction from buyers or sellers. Lingering concerns about global economic growth tempered buying interest and contributed to a further decline in U.S. Treasury yields.
The Nasdaq Composite also lost 0.1%. The Dow Jones Industrial Average and the Russell 2000 outperformed with gains of 0.1% and 0.5%, respectively.
The S&P 500 information technology (-0.4%) and financial (-0.4%) sectors dragged the broader market lower. Conversely, the consumer discretionary (+0.6%) and industrial (+0.2%) sectors outperformed.
Growth concerns were reinforced by another discouraging economic report from Germany. Germany's ifo Business Climate Index for March showed a continued deterioration of the manufacturing sector, which was notable, given Germany's status as a key export center.
U.S. Treasury yields steadily declined throughout the day on dwindling growth expectations, driving yields lower across the curve. The 2-yr yield dropped seven basis points to 2.25%, and the 10-yr yield dropped four basis points to 2.42% after briefly touching 2.39% -- its lowest level since Dec. 2017. The U.S. Dollar Index lost 0.1% to 96.53.
Homebuilding stocks outperformed amid the continued drop in rates, providing strong support for the consumer discretionary sector. The SPDR S&P Homebuilders ETF (XHB 38.17, +0.49) advanced 1.3%. The Philadelphia Semiconductor Index (-1.3%), on the other hand, pulled back from recent gains, with many of its components weighing on the tech sector.
Apple (AAPL 188.74, -2.31, -1.2%) hosted a highly-anticipated service event, in which it introduced Apple TV Plus, Apple News Plus, Apple Arcade, and Apple Card. Apple did not mention a price for its TV video service. Apple News Plus, a magazine subscription service, will cost $9.99/month. Despite the event, shares of Apple underperformed throughout the day, losing 1.2%.
In M&A news, Thermo Fisher (TMO 268.80, +4.99, +1.9%) will expand its presence into the gene therapy field after announcing it will acquire Brammer Bio for approximately $1.7 billion in cash.
Investors did not receive any U.S. economic data.
Looking ahead, investors will receive several economic reports on Tuesday: Housing Start and Building Permits for February, the FHFA Housing Price Index for January, the S&P Case-Shiller Home Price Index for January, and the Conference Board's Consumer Confidence Index for March.
- Nasdaq Composite +15.1% YTD
- Russell 2000 +12.3% YTD
- S&P 500 +11.6% YTD
- Dow Jones Industrial Average +9.4% YTD